HALO trailing returns
Halozyme Therapeutics Inc.'s 10-year annualized return is +25.7% per year (+881.9% cumulative). How Halozyme Therapeutics Inc. (HALO) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through August 13, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-08-13. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -1.1% | |
| 1 week | — | +17.4% | |
| 1 month | — | +32.7% | |
| YTD | — | +49.5% | |
| 1 year | +57.2% | +57.2% | |
| 5 years | +19.3% | +142.0% | |
| 10 years | +25.7% | +881.9% | |
| 20 years | +20.8% | +4275.7% | |
| Since inception (2004) | +15.2% | +2268.0% |
Growth of HALO#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-08-13). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from HALO's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Halozyme Therapeutics Inc.'s 10-year return?
- Over the last 10 years, Halozyme Therapeutics Inc. (HALO) returned about +25.7% a year annualized (+881.9% cumulative total return).
- What is Halozyme Therapeutics Inc.'s 20-year annualized return?
- Over the last 20 years, Halozyme Therapeutics Inc. (HALO) compounded at about +20.8% a year (+4275.7% cumulative).
- What is Halozyme Therapeutics Inc.'s return since inception?
- Since 2004, Halozyme Therapeutics Inc. (HALO) has compounded at about +15.2% a year — +2268.0% in total.